Malaga Cove Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Malaga Cove Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-49,439	Closed	-$956K	–	179
2018 Q4	$956K	Sell	49,439 -1,500	-3%	-$29.4K	0.66%	42
2018 Q3	$997K	Sell	50,939 -119	-0.2%	-$2.26K	0.54%	57
2018 Q2	$846K	Sell	51,058 -218	-0.4%	-$3.32K	0.43%	75
2018 Q1	$728K	Hold	51,276	–	–	0.39%	77
2017 Q4	$749K	Hold	51,276	–	–	0.42%	74
2017 Q3	$684K	Hold	51,276	–	–	0.39%	76
2017 Q2	$609K	Buy	+51,276	New	+$638K	0.36%	82

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Malaga Cove Capital's HZNP Position: Q1 2019 in Review

Malaga Cove Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2019, closing a stake of 49,439 shares — an estimated $956K sold.

Malaga Cove Capital first reported a position in HZNP in Q2 2017 and held it in 7 quarters. The position peaked at $997K in Q3 2018. 297 funds tracked by Wall St. Rank hold HZNP as of Q1 2019.

Malaga Cove Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2019 after selling out during the quarter.
Malaga Cove Capital sold 49,439 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2019, an estimated $956K.
Malaga Cove Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 7 quarters.
Malaga Cove Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $997K in Q3 2018.
297 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2019.

Based on Malaga Cove Capital's 13F filing for Q1 2019, filed 11 Apr 2019.